Freedonia Focus on Ethical Pharmaceuticals

This report discusses US ethical pharmaceuticals for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, regulatory and commercial status, product segmentation, health care funding, regulatory considerations, market environment, regulatory and commercial status forecasts, product forecasts, industry composition and leading participants. Product segments cover central nervous system agents, hormones and related agents, cardiovascular agents, anti-infective agents, respiratory agents, and other agents. Pharmaceutical demand by regulatory status (ethical and over-the-counter) and commercial status (proprietary and generic) is also included. This 20 page report also includes a highlights summary and a resources section.